CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EUROSARC focuses on developing and validating targeted treatment strategies for rare sarcomas, which are malignant tumors with various histological and molecular subtypes. The project aims to conduct clinical trials tailored to these specific subtypes, enhancing treatment efficacy through integrated clinical networks a…
Sarcomas are rare malignant tumors, with an overall incidence of 6/105/year.
Bone and soft tissue connective tissue tumours encompass more than 50 different rare histotypes and more than 150 different molecular subtypes.
The incidence of individual rare sarcomas subtypes is often less than 0.5/105/year.
Given sarcoma rarity as a group, but even more as individual entities, few prospective clinical trials testing local or systemic treatments have been performed in specific subtypes of sarcomas. C…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 sectors.
